Ispire Technology Inc. Reports 16.1% Revenue Decline and Increased Net Loss for Fiscal Year Ending June 30, 2025

Ispire Technology Inc. reported a significant decline in its financial performance for the fiscal year ending June 30, 2025, with total revenue of $127.5 million, down 16.1% from $151.9 million in the previous year. The company experienced a net loss of approximately $39.2 million, or $0.69 per share, compared to a loss of $14.8 million, or $0.27 per share, in the prior year. This increase in losses was attributed primarily to rising operating expenses, which surged by 38.5% to $60.5 million, driven by higher credit loss expenses and increased sales and marketing costs.

The company's revenue decline was influenced by a notable drop in sales in North America, which fell from $63.1 million to $32.6 million, while sales in Europe increased from $65.3 million to $74.1 million. The Asia Pacific region also saw a decrease in sales, contributing to the overall revenue decline. Ispire's operational strategy includes expanding its international presence and launching new products under the Ispire brand, particularly in the cannabis vaping market, which is still developing in various regions.

Ispire has made strategic moves to enhance its manufacturing capabilities, including the establishment of a new facility in Malaysia, which commenced operations in February 2024. This facility is expected to help reduce reliance on external suppliers, particularly Shenzhen Yi Jia, which is a related party and currently supplies the majority of Ispire's products. The company is also focusing on its joint venture with IKE Tech LLC, aimed at developing age-verification technology for vaping products, which could potentially facilitate the approval of flavored e-cigarettes in the U.S. market.

As of June 30, 2025, Ispire had a total of 81 employees, with a significant portion dedicated to research and development. The company is actively pursuing technological innovations to enhance product offerings and reduce youth access to vaping products. Despite the challenges faced, Ispire remains optimistic about its growth prospects, particularly in the cannabis market, as legalization efforts continue in various regions.

Looking ahead, Ispire's management has indicated that they will continue to focus on improving operational efficiencies and expanding their product portfolio. However, the company acknowledges the ongoing regulatory challenges in the vaping industry, particularly in the U.S., which could impact future sales and profitability. The management's outlook emphasizes the importance of navigating these regulatory landscapes while capitalizing on emerging market opportunities.